Logo image of CGNT

COGNYTE SOFTWARE LTD (CGNT) Stock Fundamental Analysis

NASDAQ:CGNT - Nasdaq - IL0011691438 - Common Stock - Currency: USD

9.18  -0.33 (-3.42%)

After market: 9.18 0 (0%)

Fundamental Rating

4

Overall CGNT gets a fundamental rating of 4 out of 10. We evaluated CGNT against 285 industry peers in the Software industry. While CGNT seems to be doing ok healthwise, there are quite some concerns on its profitability. CGNT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CGNT had positive earnings in the past year.
CGNT had a positive operating cash flow in the past year.
CGNT had negative earnings in 4 of the past 5 years.
CGNT had a positive operating cash flow in 4 of the past 5 years.
CGNT Yearly Net Income VS EBIT VS OCF VS FCFCGNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

CGNT has a Return On Assets (-2.42%) which is in line with its industry peers.
With a Return On Equity value of -6.08%, CGNT perfoms like the industry average, outperforming 55.09% of the companies in the same industry.
Industry RankSector Rank
ROA -2.42%
ROE -6.08%
ROIC N/A
ROA(3y)-10.49%
ROA(5y)-6.29%
ROE(3y)-24.24%
ROE(5y)-14.49%
ROIC(3y)N/A
ROIC(5y)N/A
CGNT Yearly ROA, ROE, ROICCGNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

The Gross Margin of CGNT (70.42%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CGNT has grown nicely.
CGNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y1.89%
CGNT Yearly Profit, Operating, Gross MarginsCGNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

CGNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CGNT has been increased compared to 1 year ago.
CGNT has more shares outstanding than it did 5 years ago.
CGNT has a worse debt/assets ratio than last year.
CGNT Yearly Shares OutstandingCGNT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CGNT Yearly Total Debt VS Total AssetsCGNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.72, we must say that CGNT is in the distress zone and has some risk of bankruptcy.
CGNT has a Altman-Z score of 1.72. This is comparable to the rest of the industry: CGNT outperforms 50.18% of its industry peers.
CGNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.72
ROIC/WACCN/A
WACC9.34%
CGNT Yearly LT Debt VS Equity VS FCFCGNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.30 indicates that CGNT should not have too much problems paying its short term obligations.
CGNT has a Current ratio (1.30) which is in line with its industry peers.
A Quick Ratio of 1.22 indicates that CGNT should not have too much problems paying its short term obligations.
CGNT's Quick ratio of 1.22 is on the low side compared to the rest of the industry. CGNT is outperformed by 63.51% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.22
CGNT Yearly Current Assets VS Current LiabilitesCGNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 128.57% over the past year.
CGNT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -56.72% yearly.
Looking at the last year, CGNT shows a quite strong growth in Revenue. The Revenue has grown by 11.85% in the last year.
CGNT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.17% yearly.
EPS 1Y (TTM)128.57%
EPS 3Y-56.72%
EPS 5YN/A
EPS Q2Q%113.04%
Revenue 1Y (TTM)11.85%
Revenue growth 3Y-9.56%
Revenue growth 5Y-5.17%
Sales Q2Q%12.92%

3.2 Future

The Earnings Per Share is expected to grow by 81.60% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.46% on average over the next years.
EPS Next Y171.15%
EPS Next 2Y81.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.08%
Revenue Next 2Y10.85%
Revenue Next 3Y6.46%
Revenue Next 5Y6.46%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGNT Yearly Revenue VS EstimatesCGNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100M 200M 300M 400M
CGNT Yearly EPS VS EstimatesCGNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 153.00, which means the current valuation is very expensive for CGNT.
CGNT's Price/Earnings ratio is in line with the industry average.
CGNT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.63.
CGNT is valuated quite expensively with a Price/Forward Earnings ratio of 56.43.
CGNT's Price/Forward Earnings ratio is in line with the industry average.
CGNT is valuated expensively when we compare the Price/Forward Earnings ratio to 20.85, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 153
Fwd PE 56.43
CGNT Price Earnings VS Forward Price EarningsCGNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

CGNT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CGNT is cheaper than 62.81% of the companies in the same industry.
CGNT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CGNT is cheaper than 77.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.66
EV/EBITDA 62.44
CGNT Per share dataCGNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CGNT's earnings are expected to grow with 81.60% in the coming years.
PEG (NY)0.89
PEG (5Y)N/A
EPS Next 2Y81.6%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CGNT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COGNYTE SOFTWARE LTD

NASDAQ:CGNT (4/21/2025, 8:01:26 PM)

After market: 9.18 0 (0%)

9.18

-0.33 (-3.42%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-02 2025-04-02/bmo
Earnings (Next)06-16 2025-06-16/bmo
Inst Owners78.25%
Inst Owner Change0.17%
Ins Owners2.15%
Ins Owner Change0%
Market Cap660.59M
Analysts45.71
Price Target7.65 (-16.67%)
Short Float %0.91%
Short Ratio2.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)175.89%
Min EPS beat(2)157.67%
Max EPS beat(2)194.12%
EPS beat(4)4
Avg EPS beat(4)179.96%
Min EPS beat(4)38.24%
Max EPS beat(4)329.82%
EPS beat(8)7
Avg EPS beat(8)503.28%
EPS beat(12)9
Avg EPS beat(12)270.95%
EPS beat(16)12
Avg EPS beat(16)210.89%
Revenue beat(2)0
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-0.54%
Max Revenue beat(2)-0.53%
Revenue beat(4)0
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-1.16%
Max Revenue beat(4)-0.53%
Revenue beat(8)3
Avg Revenue beat(8)-0.11%
Revenue beat(12)4
Avg Revenue beat(12)-3.63%
Revenue beat(16)5
Avg Revenue beat(16)-3.18%
PT rev (1m)0%
PT rev (3m)-9.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)120%
EPS NY rev (1m)13.93%
EPS NY rev (3m)538%
Revenue NQ rev (1m)4.81%
Revenue NQ rev (3m)7.3%
Revenue NY rev (1m)4.82%
Revenue NY rev (3m)4.82%
Valuation
Industry RankSector Rank
PE 153
Fwd PE 56.43
P/S 1.88
P/FCF 19.66
P/OCF 14.12
P/B 3.33
P/tB 9.17
EV/EBITDA 62.44
EPS(TTM)0.06
EY0.65%
EPS(NY)0.16
Fwd EY1.77%
FCF(TTM)0.47
FCFY5.09%
OCF(TTM)0.65
OCFY7.08%
SpS4.87
BVpS2.75
TBVpS1
PEG (NY)0.89
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.42%
ROE -6.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.42%
FCFM 9.58%
ROA(3y)-10.49%
ROA(5y)-6.29%
ROE(3y)-24.24%
ROE(5y)-14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y1.89%
F-Score6
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 96.6%
Cap/Sales 3.76%
Interest Coverage N/A
Cash Conversion 533.19%
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 1.22
Altman-Z 1.72
F-Score6
WACC9.34%
ROIC/WACCN/A
Cap/Depr(3y)75.65%
Cap/Depr(5y)79.28%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)128.57%
EPS 3Y-56.72%
EPS 5YN/A
EPS Q2Q%113.04%
EPS Next Y171.15%
EPS Next 2Y81.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.85%
Revenue growth 3Y-9.56%
Revenue growth 5Y-5.17%
Sales Q2Q%12.92%
Revenue Next Year12.08%
Revenue Next 2Y10.85%
Revenue Next 3Y6.46%
Revenue Next 5Y6.46%
EBIT growth 1Y71.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year281.75%
EBIT Next 3Y75.38%
EBIT Next 5Y60.6%
FCF growth 1Y31.78%
FCF growth 3YN/A
FCF growth 5Y-6.04%
OCF growth 1Y35.36%
OCF growth 3Y161.04%
OCF growth 5Y-6.98%